Intermediate-Timed Alemtuzumab May be Associated with...

Biology of Blood and Marrow Transplantation 2018 / 03 Vol. 24; Iss. 3

Intermediate-Timed Alemtuzumab May be Associated with Increased Graft Rejection in Reduced-Intensity Bone Marrow Transplant for Sickle Cell Disease

Patel, Krupesh, Agarwal, Shreya, Durning, Nancy, Hankewycz, Melanie, Gillio, Alfred P., Adler-Brecher, Barbara, Haugh, Jeanette, Krajewski, Jennifer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.391
Date:
March, 2018
File:
PDF, 120 KB
2018
Conversion to is in progress
Conversion to is failed